Evaluation of Changes Induced in the Probiotic Escherichia coli M17 Following Recurrent Exposure to Antimicrobials
Journal of Pharmaceutical Research International,
Introduction: It is already well known that the exposure of certain bacteria, pathogenic or not, to antimicrobials is likely to increase their virulence and induce the development of direct or cross resistance to antimicrobials, but there is almost no information available regarding probiotics.
Aim: To assess the changes induced in susceptibility to antibiotics, biofilm formation, growth rate and relative pathogenicity in the probiotic Escherichia coli M17 (EC-M17) after long exposure to antimicrobials namely ampicillin, kanamycin, cefazolin and silver nanoparticles (AgNPs).
Methods: After determining the minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) of the 4 antimicrobials above-mentioned by the microdilution method, EC-M17 was exposed to increasing subinhibitory doses ranging from MIC/8 to MIC for 8 days. The susceptibility to antibiotics of the mutants obtained was assessed by the Kirby Bauer disc diffusion method, biofilm formation by the Congo red agar method and with crystal violet bacterial attachment assay, and relative pathogenicity was assessed using a Galleria melonella waxworm model.
Results: Exposure to antimicrobials induces noticeable changes in EC-M17. The highest adaptation to antimicrobials was observed on AgNPs with 8-fold increase in MIC and 16-fold increase in MBC of AgNPs. EC-M17 exposed to ampicillin, kanamycin and silver nanoparticles became resistant to ampicillin, ceftazidime, ceftazidime/clavulanate and tetracycline while exposure to cefazolin induced a significant decrease in sensitivity to tetracycline and ampicillin and resistance to ceftazidime/clavulanate and ceftazidime. The strain exposed to ampicillin was the only one to produce more biofilm than the control strain and except the EC-M17 exposed to cefazolin, all other EC-M17 strains were more pathogenic on G. melonella model than the control.
Conclusion: Data in this investigation suggest that repeated exposure of the probiotic EC-M17 to antimicrobials may induce changes in antimicrobials susceptibility, biofilm formation, growth rate, and relative pathogenicity. Therefore, as far as possible, the probiotic E. coli M17 should not be used in combination with antibiotics and further investigations are required to expand similar work on more probiotics in order to avoid resistance build-up which might be transmitted by horizontal transfer.
- Escherichia coli M17
- susceptibility to antibiotics
- biofilm formation
- growth rate
- motility and pathogenicity
How to Cite
Fitzpatrick LR, Small J, Hoerr RA, Bostwick EF, Maines L, Koltun WA. In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: Immunomodulation and attenuation of murine colitis. British Journal of Nutrition. 2008;100(3):530-541.
Kokesova A, Frolova L, Kvberka M, Sokol D, Rossmann P, Bartova J, Tlaskalova-Hogenova H. Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice. Folia Microbiol (Praha). 2006;51:478–484.
Clinical trial NCT00194922.
Last accessed: May 7, 2021
Adler SN, Jacob H, Eliakim R. The probiotic agent E coli strain ATCC 20226 has a healing effect on proximal inﬂammation in the small bowel (Abstract). Gastroenterology. 2003;120:A-527.
Bogomolov BP, Genina GS. Lmjojyecka> OxeokaivvektjBoOCTj kOmjbakTepjoa qpjm eyeojj bOM:o:IX ejieotepjekj edO poomj BBocctaHoBmeojj bjoxeooia (Clinical evaluation of colibacterin in the treatment of patients with dysentery and its role in restoration of biocenosis). Ter Arkh. 1979;51:94–98.
Kurnosova NA, Zatsepin IuK, Feklisova LV. Bjomodjyeckje qpeqapat:IBkOMqmekcooktepaqjj eetek – pe kooBamecxeoTOB qocme ejieotepjj (Biological preparations in the overall therapy of children convalescing after dysentery). Zh Mikrobiol Epidemiol Immunobiol. 1979;21–25.
Henly EL, Dowling JAR, Maingay JB, Lacey MM, Smith TJ, Forbes S. Biocide exposure induces changes in susceptibility, pathogenicity, and biofilm formation in uropathogenic Escherichia coli. Antimicrobial agents and chemotherapy. 2019;63(3):e01892-18.
Yen P, Papin JA. History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment. PLoS Biology. 2017;15(8):e2001586.
Kampf G. Biocidal agents used for disinfection can enhance antibiotic resistance in gram-negative species. Antibiotics. 2018;7(4):110.
Sonbol FI, El‐Banna TE, Abd El‐Aziz AA, El‐Ekhnawy E. Impact of triclosan adaptation on membrane properties, efflux and antimicrobial resistance of Escherichia coli clinical isolates. Journal of applied microbiology. 2019;126(3):730-739.
Voumard M, Venturelli L, Borgatta M, Croxatto A, Kasas S, Dietler G, von Gunten U. Adaptation of Pseudomonas aeruginosa to constant sub-inhibitory concentrations of quaternary ammonium compounds. Environmental Science: Water Research & Technology. 2020;6(4):1139-1152.
Sun S, Korheina DK, Fu H, Ge X. Chronic exposure to dietary antibiotics affects intestinal health and antibiotic resistance gene abundance in oriental river prawn (Macrobrachium nipponense), and provokes human health risk. Science of the Total Environment. 2020;720: 137478.
Veiga A, Maria da Graça TT, Rossa LS, Mengarda M, Stofella NC, Oliveira LJ, Murakami FS. Colorimetric microdilution assay: Validation of a standard method for determination of MIC, IC50%, and IC90% of antimicrobial compounds. J. Microbiol. Methods. 2019;162:50-61.
Mbarga MJ, Andreevna SL, Viktorovna PI. Evaluation of apparent microflora and study of antibiotic resistance of coliforms isolated from the shells of poultry eggs in Moscow-Russia. Journal of Advances in Microbiology. 2020;20(4):70-77.
NCCLs: Clinical & Laboratory Standards Institute. Control methods. Biological and micro-biological factors: Determination of the sensitivity of microorganisms to antibacterial drugs. Federal Center for Sanitary and Epidemiological Surveillance of Ministry of Health of Russia; 2019.
Shrestha LB, Bhattarai NR, Khanal B. Comparative evaluation of methods for the detection of biofilm formation in coagulase-negative staphylococci and correlation with antibiogram. Infection and drug resistance. 2018;11:607.
Furtuna DK, Debora K, Wasito EB. Comparison of microbiological examination by test tube and congo red agar methods to detect biofilm production on clinical isolates. Folia Medica Indonesiana. 2018;54(1):22-28.
Sohanang FSN, Coton M, Debaets S, Coton E, Tatsadjieu LN, Mohammadou BA. Bacterial diversity of traditional fermented milks from Cameroon and safety and antifungal activity assessment for selected lactic acid bacteria. LWT. 2021;138:110635.
Neut C, Mahieux S, Dubreuil LJ. Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?. Medecine et maladies infectieuses. 2017;47(7):477-483.
De Wolfe TJ, Eggers S, Barker AK, Kates AE, Dill-McFarland KA, Suen G, Safdar N. Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection. PLoS One. 2018;13(9):e0204253.
Elkrewi E, Randall CP, Ooi N, Cottell JL, O’Neill AJ. Cryptic silver resistance is prevalent and readily activated in certain Gram-negative pathogens. J Antimicrob Chemother. 2017;72:3043–3046.
Sutterlin S, Dahlo M, Tellgren-Roth C, Schaal W, Melhus A. High frequency of silver resistance genes in invasive isolates of Enterobacter and Klebsiella species. J Hosp Infect. 2017;96:256–261.
DOI: 10 .1016/j.jhin.2017.04.017
Randall CP, Gupta A, Jackson N, Busse D, O’Neill AJ. Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms. J Antimicrob Chemother. 2015;70:1037–1046.
Li XZ, Nikaido H, Williams KE. Silver-resistant mutants of Escherichia coli display active efﬂux of Ag and are deﬁcient in porins. J Bacteriol. 1997;179:6127–6132.
Machado I, Lopes SP, Sousa AM, Pereira MO. Adaptive response of single and binary Pseudomonas aeruginosa and Escherichia coli bioﬁlms to benzalkonium chloride. J Basic Microbiol. 2012;52:43– 52.
DOI: 10 .1002/jobm.201100137
Niba ET, Naka Y, Nagase M, Mori H, Kitakawa M. A genome-wide approach to identify the genes involved in bioﬁlm formation in E. coli. DNA Res. 2007;14:237–246.
Abstract View: 0 times
PDF Download: 0 times